Skip to main content
. 2019 Mar 1;9:3257. doi: 10.1038/s41598-019-40125-4

Figure 1.

Figure 1

Schematic representation of the corresponding target sites on HIV-1 gp41 glycoprotein of the selected peptide inhibitors: HPgV (45–64) E2 peptide and HPgV (139–156) E1 peptide. Primary sequences of the DT-peptides, DT-P1 and DT-P2, are depicted at the bottom of the figure.